Annual General Meeting of Shareholders to be held on June 30, 2022René Beukema joins management team as Chief Corporate Development Officer and General Counsel and is nominated to Management BoardGerard Platenburg to assume Chief Scientific Officer role, with le
Senior leader with extensive global rare disease commercialization experience
Top-line data from Phase 2/3 pivotal Illuminate trial of sepofarsen for CEP290-mediated LCA10 on track for H1 2022
LEIDEN, Netherlands & CAMBRIDGE, Mass., June 18, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it will participate in the RNA Editing Summit, June 18-20, 2024, in Boston, Mas
… biotechnology or pharmaceutical industry, with a proven leadership role in clinical development or related functions, … clinical sites, patient organizations, and CROs. Excellent leadership, communication, strategic thinking, and analytical …
… As Principal Scientist Liver , you will provide scientific leadership for our liver programs, driving the discovery and … and non-scientific stakeholders, including senior leadership. We expect our Principal Scientist Liver to have: …